Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores
- PMID: 34897559
- PMCID: PMC8665857
- DOI: 10.1186/s13613-021-00956-9
Predicting 90-day survival of patients with COVID-19: Survival of Severely Ill COVID (SOSIC) scores
Abstract
Background: Predicting outcomes of critically ill intensive care unit (ICU) patients with coronavirus-19 disease (COVID-19) is a major challenge to avoid futile, and prolonged ICU stays.
Methods: The objective was to develop predictive survival models for patients with COVID-19 after 1-to-2 weeks in ICU. Based on the COVID-ICU cohort, which prospectively collected characteristics, management, and outcomes of critically ill patients with COVID-19. Machine learning was used to develop dynamic, clinically useful models able to predict 90-day mortality using ICU data collected on day (D) 1, D7 or D14.
Results: Survival of Severely Ill COVID (SOSIC)-1, SOSIC-7, and SOSIC-14 scores were constructed with 4244, 2877, and 1349 patients, respectively, randomly assigned to development or test datasets. The three models selected 15 ICU-entry variables recorded on D1, D7, or D14. Cardiovascular, renal, and pulmonary functions on prediction D7 or D14 were among the most heavily weighted inputs for both models. For the test dataset, SOSIC-7's area under the ROC curve was slightly higher (0.80 [0.74-0.86]) than those for SOSIC-1 (0.76 [0.71-0.81]) and SOSIC-14 (0.76 [0.68-0.83]). Similarly, SOSIC-1 and SOSIC-7 had excellent calibration curves, with similar Brier scores for the three models.
Conclusion: The SOSIC scores showed that entering 15 to 27 baseline and dynamic clinical parameters into an automatable XGBoost algorithm can potentially accurately predict the likely 90-day mortality post-ICU admission (sosic.shinyapps.io/shiny). Although external SOSIC-score validation is still needed, it is an additional tool to strengthen decisions about life-sustaining treatments and informing family members of likely prognosis.
Keywords: Acute respiratory distress syndrome; COVID-19; Mechanical ventilation; Outcome; Predictive survival model.
© 2021. The Author(s).
Conflict of interest statement
Dr. Schmidt reports receiving personal fees from Getinge, Drager, and Xenios, outside the submitted work. Dr. Demoule reports receiving: personal fees from Medtronic; grants, personal fees and non-financial support from Philips; personal fees from Baxter; personal fees from Hamilton; personal fees and non-financial support from Fisher & Paykel; grants from French Ministry of Health; personal fees from Getinge; grants and personal fees from Respinor; grants and non-financial support from Lungpacer; outside the submitted work. Dr. Combes reports grants from Getinge, personal fees from Getinge, Baxter and Xenios outside the submitted work. No other disclosures were reported.
Figures




References
-
- Karagiannidis C, Mostert C, Hentschker C, Voshaar T, Malzahn J, Schillinger G, et al. Case characteristics, resource use, and outcomes of 10 021 patients with COVID-19 admitted to 920 German hospitals: an observational study. Lancet Respir Med. 2020;8:853–862. doi: 10.1016/S2213-2600(20)30316-7. - DOI - PMC - PubMed
LinkOut - more resources
Full Text Sources